Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301585635> ?p ?o ?g. }
- W4301585635 abstract "Diabetic neuropathy (DN) is a serious microvascular complication of diabetes mellitus (DM) that impacts the nervous system. Several risk factors are involved in the progression and maintenance of DN-associated pain, such as higher expression of various inflammatory mediators, e.g., tumor necrotic factor-alpha (TNF-α), nuclear factor-kappa B (NF-κB), and cyclo-oxygenase-2 (COX-2). The present research explores the neuroprotective potential of natural isolates, including berbamine, bergapten, and carveol, on the DM-induced neuroinflammation and neurodegeneration that cause neuropathic pain. The study utilized computerized techniques, including computational analysis (a docking assay and a molecular dynamic simulation) before moving to in vivo protocols. Diabetic neuropathy was induced by intraperitonial injection (IP) of streptozotocin (65 mg/kg), and the animal subjects (rats) were kept for 4 weeks for the development of DN. Once diabetic neuropathy was confirmed, the subjects were treated with berbamine, bergapten, and carveol until the sixth week (i.e., 2 weeks of treatment). At the sixth week, the rats were sacrificed, and the sciatic nerve and spinal cord of each was collected for further molecular investigation. Docking and a molecular dynamic simulation (MDS) delivered the information that the natural compounds (berbamine, bergapten, and carveol) were interacting with the selected target protein (i.e., mitogen-activated protein kinase). After IP, it was found that berbamine, bergapten, and carveol had ameliorated mechanical allodynia and thermal hyperalgesia by the 28th day of the study (2 weeks after treatment) without affecting blood glucose levels. Berbamine, bergapten, and carveol markedly elevated the levels of glutathione (GSH) and glutathione s-transferase (GST), in both the sciatic nerve and spinal cord, and also reduced lipid peroxidase (LPO) and nitric oxide (NO). The abovementioned natural isolates reduced pathologic alterations provoked through DN, a finding confirmed through histopathological assays (hematoxylin and eosin staining and immuno-histochemical analysis). Treatment down regulated higher expressions of the inflammatory mediatorcyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and nuclear factor kappa B (NF-κB), as confirmed by ELISA and polymerase chain reaction (PCR). The outcomes of berbamine, bergapten, and carveol are compared with those of pregabalin as a positive control group. Compared to pregabalin, treatment with the aforementioned three natural compounds improved nociception and reduced hyperalgesic effects, and consequently reduced pain perception and inflammation. Our results suggest the mechanism for the neuro-protective impact of berbamine, bergapten, and carveol might possibly be arbitrated via COX-2, TNF-α, and NF-κB, and regulated by mitogen-activated protein kinase, ultimately ameliorating STZ-provoked, DM-induced neuroinflammation and neurodegeneration, and associated neuropathic pain." @default.
- W4301585635 created "2022-10-05" @default.
- W4301585635 creator A5004970725 @default.
- W4301585635 creator A5013616631 @default.
- W4301585635 creator A5077362915 @default.
- W4301585635 creator A5083560821 @default.
- W4301585635 date "2022-10-05" @default.
- W4301585635 modified "2023-10-01" @default.
- W4301585635 title "Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain" @default.
- W4301585635 cites W1967776969 @default.
- W4301585635 cites W1976828967 @default.
- W4301585635 cites W1979859079 @default.
- W4301585635 cites W1980129179 @default.
- W4301585635 cites W1983072558 @default.
- W4301585635 cites W1984458940 @default.
- W4301585635 cites W1995314688 @default.
- W4301585635 cites W2020267609 @default.
- W4301585635 cites W2030564776 @default.
- W4301585635 cites W2035196216 @default.
- W4301585635 cites W2039718439 @default.
- W4301585635 cites W2052515306 @default.
- W4301585635 cites W2077023300 @default.
- W4301585635 cites W2077183782 @default.
- W4301585635 cites W2077939735 @default.
- W4301585635 cites W2098587915 @default.
- W4301585635 cites W2107312159 @default.
- W4301585635 cites W2114125742 @default.
- W4301585635 cites W2138526449 @default.
- W4301585635 cites W2144353365 @default.
- W4301585635 cites W2154640194 @default.
- W4301585635 cites W2158899276 @default.
- W4301585635 cites W2171428509 @default.
- W4301585635 cites W2477369408 @default.
- W4301585635 cites W2504800334 @default.
- W4301585635 cites W2603565334 @default.
- W4301585635 cites W2611373298 @default.
- W4301585635 cites W2808969679 @default.
- W4301585635 cites W2885291208 @default.
- W4301585635 cites W2905371686 @default.
- W4301585635 cites W2946269821 @default.
- W4301585635 cites W2966158858 @default.
- W4301585635 cites W2991785976 @default.
- W4301585635 cites W2999346870 @default.
- W4301585635 cites W3000358800 @default.
- W4301585635 cites W3010656014 @default.
- W4301585635 cites W3019539493 @default.
- W4301585635 cites W3024577764 @default.
- W4301585635 cites W3042741494 @default.
- W4301585635 cites W3081892330 @default.
- W4301585635 cites W3092906221 @default.
- W4301585635 cites W3120570340 @default.
- W4301585635 cites W3128092664 @default.
- W4301585635 cites W3168966033 @default.
- W4301585635 cites W3205047351 @default.
- W4301585635 cites W3208458055 @default.
- W4301585635 cites W4289521594 @default.
- W4301585635 doi "https://doi.org/10.3389/fphar.2022.1019033" @default.
- W4301585635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278164" @default.
- W4301585635 hasPublicationYear "2022" @default.
- W4301585635 type Work @default.
- W4301585635 citedByCount "1" @default.
- W4301585635 countsByYear W43015856352022 @default.
- W4301585635 crossrefType "journal-article" @default.
- W4301585635 hasAuthorship W4301585635A5004970725 @default.
- W4301585635 hasAuthorship W4301585635A5013616631 @default.
- W4301585635 hasAuthorship W4301585635A5077362915 @default.
- W4301585635 hasAuthorship W4301585635A5083560821 @default.
- W4301585635 hasBestOaLocation W43015856351 @default.
- W4301585635 hasConcept C126322002 @default.
- W4301585635 hasConcept C134018914 @default.
- W4301585635 hasConcept C15490471 @default.
- W4301585635 hasConcept C170493617 @default.
- W4301585635 hasConcept C25498285 @default.
- W4301585635 hasConcept C2776914184 @default.
- W4301585635 hasConcept C2777107010 @default.
- W4301585635 hasConcept C2777883359 @default.
- W4301585635 hasConcept C2779178840 @default.
- W4301585635 hasConcept C2779245659 @default.
- W4301585635 hasConcept C2779280383 @default.
- W4301585635 hasConcept C555293320 @default.
- W4301585635 hasConcept C71924100 @default.
- W4301585635 hasConcept C87753298 @default.
- W4301585635 hasConcept C98274493 @default.
- W4301585635 hasConceptScore W4301585635C126322002 @default.
- W4301585635 hasConceptScore W4301585635C134018914 @default.
- W4301585635 hasConceptScore W4301585635C15490471 @default.
- W4301585635 hasConceptScore W4301585635C170493617 @default.
- W4301585635 hasConceptScore W4301585635C25498285 @default.
- W4301585635 hasConceptScore W4301585635C2776914184 @default.
- W4301585635 hasConceptScore W4301585635C2777107010 @default.
- W4301585635 hasConceptScore W4301585635C2777883359 @default.
- W4301585635 hasConceptScore W4301585635C2779178840 @default.
- W4301585635 hasConceptScore W4301585635C2779245659 @default.
- W4301585635 hasConceptScore W4301585635C2779280383 @default.
- W4301585635 hasConceptScore W4301585635C555293320 @default.
- W4301585635 hasConceptScore W4301585635C71924100 @default.
- W4301585635 hasConceptScore W4301585635C87753298 @default.
- W4301585635 hasConceptScore W4301585635C98274493 @default.
- W4301585635 hasLocation W43015856351 @default.
- W4301585635 hasLocation W43015856352 @default.